Tumor necrosis factor-related apoptosis-inducing ligand Receptor 2 (TRAIL-R2) is a cell-surface receptor involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling. The death ligand TRAIL bears high potential as a new anticancer agent, as binding to the death receptors TRAIL-R1 or TRAIL-R2 triggers apoptosis in most cancer cells. TRAIL-R2 has been shown to be associated with a decrease in the survival rates of breast cancer patients.
Reference
1. Pordzik S, Petrovici K, Schmid C, et al. 2011. Hematology, 16: 341-50
2. Tseng HY, Chen LH, Ye Y, et al. 2012. Carcinogenesis, 33: 1871-81
3. Bae SI, Cheriyath V, Jacobs BS, et al. 2008. Oncogene, 27: 490-8
4. Camidge DR. 2008. Expert Opin Biol Ther, 8: 1167-76.